HB 2231 Missouri House · 2026 Regular Session

Establishes requirements for dual diagnosis treatment centers

HB 2231 requires facilities advertising dual diagnosis treatment (addressing both substance use disorders and mental health conditions) to meet specific operational standards. It mandates medication management systems for tracking prescriptions, regular patient reviews, and education; requires integrated, evidence-based treatment plans tailored to individual patients; and prohibits misleading advertising claims about services or licensure. Facilities must clearly disclose their credentials in all marketing materials. The Department of Mental Health enforces these rules, with violations subject to penalties under existing licensing laws. This bill directly affects all treatment centers in the state that market themselves as providing dual diagnosis care.
Bill status in committee 1 of 4 stages cleared
Introduction
Dec 2025
Committee Review
Floor Vote
Governor
Introduced Dec 5, 2025 Last action May 15, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
4
Key actions
0
Committee
1
May 15, 2026
Committee
Referred: Emerging Issues(H)
lower
Dec 5, 2025
Introduced
Prefiled (H)
lower
1 primary · 1 co-sponsor

Sponsors